<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26849113</article-id>
<article-id pub-id-type="pmc">4746372</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(15)00512-1</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2015.12.017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Disease and Polygenic Architecture: Avoid Trio Design and Appropriately Account for Unscreened Control Subjects for Common Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Peyrot</surname>
<given-names>Wouter J.</given-names>
</name>
<email>w.peyrot@ggzingeest.nl</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boomsma</surname>
<given-names>Dorret I.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Penninx</surname>
<given-names>Brenda W.J.H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wray</surname>
<given-names>Naomi R.</given-names>
</name>
<email>naomi.wray@uq.edu.au</email>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Psychiatry, VU University Medical Center &amp; GGZ inGeest, Amsterdam 1081 HL, the Netherlands</aff>
<aff id="aff2"><label>2</label>Queensland Brain Institute, University of Queensland, Brisbane 4072, Australia</aff>
<aff id="aff3"><label>3</label>Department of Biological Psychology, VU University Amsterdam, Amsterdam 1081 BT, the Netherlands</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>w.peyrot@ggzingeest.nl</email></corresp>
<corresp id="cor2"><label>∗∗</label>Corresponding author <email>naomi.wray@uq.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>04</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>2</month>
<year>2016</year>
</pub-date>
<volume>98</volume>
<issue>2</issue>
<fpage>382</fpage>
<lpage>391</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>©2016 by The American Society of Human Genetics. All rights reserved.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society of Human Genetics</copyright-holder>
</permissions>
<abstract>
<p>Genome-wide association studies (GWASs) are an optimal design for discovery of disease risk loci for diseases whose underlying genetic architecture includes many common causal loci of small effect (a polygenic architecture). We consider two designs that deserve careful consideration if the true underlying genetic architecture of the trait is polygenic: parent-offspring trios and unscreened control subjects. We assess these designs in terms of quantification of the total contribution of genome-wide genetic markers to disease risk (SNP heritability) and power to detect an associated risk allele. First, we show that trio designs should be avoided when: (1) the disease has a lifetime risk &gt; 1%; (2) trio probands are ascertained from families with more than one affected sibling under which scenario the SNP heritability can drop by more than 50% and power can drop as much as from 0.9 to 0.15 for a sample of 20,000 subjects; or (3) assortative mating occurs (spouse correlation of the underlying liability to the disorder), which decreases the SNP heritability but not the power to detect a single locus in the trio design. Some studies use unscreened rather than screened control subjects because these can be easier to collect; we show that the estimated SNP heritability should then be scaled by dividing by (1 − <italic>K</italic> × <italic>u</italic>)<sup>2</sup> for disorders with population prevalence <italic>K</italic> and proportion of unscreened control subjects <italic>u</italic>. When omitting to scale appropriately, the SNP heritability of, for example, major depressive disorder (<italic>K</italic> = 0.15) would be underestimated by 28% when none of the control subjects are screened.</p>
</abstract>
</article-meta>
<notes>
<p id="misc0010">Published: February 4, 2016</p>
</notes>
</front>
</article>
</pmc-articleset>